BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 24120098)

  • 1. [Association between inflammatory markers and microbial translocation in patients with human immunodeficiency virus infection taking antiretroviral treatment].
    Reus Bañuls S; Portilla Sogorb J; Sanchez-Paya J; Boix Martínez V; Giner Oncina L; Frances R; Such J; Merino Lucas E; Gimeno Gascón A
    Med Clin (Barc); 2014 Jan; 142(2):47-52. PubMed ID: 24120098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-level HIV viremia is associated with microbial translocation and inflammation.
    Reus S; Portilla J; Sánchez-Payá J; Giner L; Francés R; Such J; Boix V; Merino E; Gimeno A
    J Acquir Immune Defic Syndr; 2013 Feb; 62(2):129-34. PubMed ID: 23018379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating interleukin-6 levels correlate with residual HIV viraemia and markers of immune dysfunction in treatment-controlled HIV-infected patients.
    Bastard JP; Soulié C; Fellahi S; Haïm-Boukobza S; Simon A; Katlama C; Calvez V; Marcelin AG; Capeau J
    Antivir Ther; 2012; 17(5):915-9. PubMed ID: 22436412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Is it posible to reduce the human immunodeficiency virus-associated chronic inflammation?].
    Rocafort M; Paredes R
    Med Clin (Barc); 2014 Jan; 142(2):64-6. PubMed ID: 24216015
    [No Abstract]   [Full Text] [Related]  

  • 5. Eradication of Hepatitis C Virus (HCV) Reduces Immune Activation, Microbial Translocation, and the HIV DNA Level in HIV/HCV-Coinfected Patients.
    López-Cortés LF; Trujillo-Rodríguez M; Báez-Palomo A; Benmarzouk-Hidalgo OJ; Dominguez-Molina B; Milanés-Guisado Y; Espinosa N; Viciana P; Gutiérrez-Valencia A
    J Infect Dis; 2018 Jul; 218(4):624-632. PubMed ID: 29986086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of HIV Infection and Anti-Retroviral Therapy on the Immune Profile of and Microbial Translocation in HIV-Infected Children in Vietnam.
    Bi X; Ishizaki A; Nguyen LV; Matsuda K; Pham HV; Phan CT; Ogata K; Giang TT; Phung TT; Nguyen TT; Tokoro M; Pham AN; Khu DT; Ichimura H
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27490536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection.
    Jiang W; Lederman MM; Hunt P; Sieg SF; Haley K; Rodriguez B; Landay A; Martin J; Sinclair E; Asher AI; Deeks SG; Douek DC; Brenchley JM
    J Infect Dis; 2009 Apr; 199(8):1177-85. PubMed ID: 19265479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal microbiota, microbial translocation, and systemic inflammation in chronic HIV infection.
    Dinh DM; Volpe GE; Duffalo C; Bhalchandra S; Tai AK; Kane AV; Wanke CA; Ward HD
    J Infect Dis; 2015 Jan; 211(1):19-27. PubMed ID: 25057045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus load in children infected with human immunodeficiency virus type 1 in Uganda.
    Petrara MR; Penazzato M; Massavon W; Nabachwa S; Nannyonga M; Mazza A; Gianesin K; Del Bianco P; Lundin R; Sumpter C; Zanchetta M; Giaquinto C; De Rossi A
    J Infect Dis; 2014 Aug; 210(3):392-9. PubMed ID: 24550442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal vitamin D plasma levels are associated with lower bacterial DNA translocation in HIV/hepatitis c virus coinfected patients.
    García-Álvarez M; Berenguer J; Jiménez-Sousa MÁ; Vázquez-Morón S; Carrero A; Gutiérrez-Rivas M; Aldámiz-Echevarría T; López JC; García-Broncano P; Resino S
    AIDS; 2016 Apr; 30(7):1069-74. PubMed ID: 27032111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D status in Well-Controlled Caucasian HIV Patients in Relation to Inflammatory and Metabolic Markers--A Cross-Sectional Cohort Study in Sweden.
    Missailidis C; Höijer J; Johansson M; Ekström L; Bratt G; Hejdeman B; Bergman P
    Scand J Immunol; 2015 Jul; 82(1):55-62. PubMed ID: 25833795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of antiretroviral therapy on oxidative stress and cardiovascular risk: a prospective cross-sectional study in HIV-infected patients.
    Masiá M; Padilla S; Bernal E; Almenar MV; Molina J; Hernández I; Graells ML; Gutiérrez F
    Clin Ther; 2007 Jul; 29(7):1448-55. PubMed ID: 17825696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased gut microbial translocation in HIV-infected children persists in virologic responders and virologic failures after antiretroviral therapy.
    Pilakka-Kanthikeel S; Huang S; Fenton T; Borkowsky W; Cunningham CK; Pahwa S
    Pediatr Infect Dis J; 2012 Jun; 31(6):583-91. PubMed ID: 22333700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of inflammatory cytokines and endothelial adhesion molecules with immunological, virological, and cardiometabolic disease in HIV-infected individuals.
    Lacerda HR; Falcão Mda C; de Albuquerque VM; Zírpoli JC; Miranda-Filho Dde B; de Albuquerque Mde F; Montarroyos U; Ximenes RA
    J Interferon Cytokine Res; 2014 May; 34(5):385-93. PubMed ID: 24359573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between different methods to measure microbial translocation and its association with immune activation in long-term suppressed HIV-1-infected individuals.
    Abad-Fernández M; Vallejo A; Hernández-Novoa B; Díaz L; Gutiérrez C; Madrid N; Muñoz MA; Moreno S
    J Acquir Immune Defic Syndr; 2013 Oct; 64(2):149-53. PubMed ID: 24047967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of anemia and correlation with biomarkers and specific antiretroviral regimens in 9690 human-immunodeficiency-virus-infected patients: findings of the Anemia Prevalence Study.
    Mildvan D; Creagh T; Leitz G;
    Curr Med Res Opin; 2007 Feb; 23(2):343-55. PubMed ID: 17288689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subclinical atherosclerosis in low Framingham risk HIV patients.
    León R; Reus S; López N; Portilla I; Sánchez-Payá J; Giner L; Boix V; Merino E; Torrús D; Moreno-Pérez Ó; Portilla J
    Eur J Clin Invest; 2017 Aug; 47(8):591-599. PubMed ID: 28664622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbial Translocation Does Not Drive Immune Activation in Ugandan Children Infected With HIV.
    Fitzgerald FC; Lhomme E; Harris K; Kenny J; Doyle R; Kityo C; Shaw LP; Abongomera G; Musiime V; Cook A; Brown JR; Brooks A; Owen-Powell E; Gibb DM; Prendergast AJ; Sarah Walker A; Thiebaut R; Klein N;
    J Infect Dis; 2019 Jan; 219(1):89-100. PubMed ID: 30107546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.